Abstract:Objective To explore the application value of self-management plan in hypertensive chronic nephropathy patients with deficiency both of qi and yin combined with dampness syndrome.Methods A total of 128 patients with hypertensive chronic nephropathy with deficiency both of qi and yin combined with dampness syndrome diagnosed and treated by the Third People's Hospital of Jingdezhen from February to August 2023 were selected as research objects.According to random number table method,they were divided into observation group (self-management program)and control group(routine care),64 cases each.Systolic blood pressure,diastolic blood pressure,serum creatinine(Scr),urinary albumin excretion rate(UAER)and microalbumin(mALB),self-management behavior and quality of life were compared between the two groups at 24 h.Results After intervention,24 h systolic blood pressure,diastolic blood pressure,Scr,UAER and mALB in observation group were lower than those in control group,with statistical significances (P<0.05).The proportion of reasonable exercise,salt intake control,psychological adjustment,blood pressure monitoring,regular medication and regular review in observation group was higher than that in control group,with statistical significances (P<0.05).The scores of physiological function(PF),role physical(RP),boby pain(BP),general health(GH),vitality(VT),social function(SF),role emotional(RE)and mental health (MH)in the observation group were higher than those in the control group,with statistical significances(P<0.05).Conclusion The application of self-management plan in patients with hypertensive chronic nephropathy with deficiency both of qi and yin combined with dampness syndrome is beneficial to reduce blood pressure,improve kidney function and quality of life.
王玉婷; 朱小红; 汪水发; 刘美玲; 王玲丽. 自我管理计划在气阴两虚兼湿浊证高血压慢性肾脏病患者中的应用[J]. 中国当代医药, 2024, 31(15): 166-171.
WANG Yuting ZHU Xiaohong WANG Shuifa LIU Meiling WANG Lingli. Application of self-management plan in hypertensive chronic nephropathy patients with deficiency both of qi and yin combined with dampness syndrome. 中国当代医药, 2024, 31(15): 166-171.
Kuzmin OB,Zhezha VV,Belyanin VV.Dihydropyridine calcium channel blockers for the renoprotective therapy of hypertensive patients with chronic kidney disease[J].Nephrology(Saint-Petersburg),2021,25(2):27-34.